Your browser doesn't support javascript.
loading
Japanese Dermatological Association Guidelines: outlines of guidelines for cutaneous squamous cell carcinoma 2020
Ansai, Shin-Ichi; Umeayashi, Yoshihiro; Katsumata, Noriyuki; Kato, Hiroshi; Kadono, Takafumi; Takai, Toshihiro; Namiki, Takeshi; Nakagawa, Masahiro; Soejima, Toshinori; Koga, Hiroshi; Sugaya, Makoto.
Afiliação
  • Ansai, Shin-Ichi; Nippon Medical School Musashi Kosugi-Hospital. Division of Dermatology and Dermatopathology. Kawasaki. JP
  • Umeayashi, Yoshihiro; Tokyo Medical University Hachioji Medical Center. Department of Dermatology. Hachioji. JP
  • Katsumata, Noriyuki; Nippon Medical School Musashi Kosugi-Hospital. Department of Medical Oncology. Kawasaki. JP
  • Kato, Hiroshi; Nagoya City University Graduate School of Medical Sciences. Department of Geriatric and Environmental Dermatology. Nagoya. JP
  • Kadono, Takafumi; St. Marianna University School of Medicine. Department of Dermatology. Kawasaki. JP
  • Takai, Toshihiro; Hyogo Cancer Center. Department of Dermatology. Akashi. JP
  • Namiki, Takeshi; Tokyo Medical and Dental University. Graduate School of Medical and Dental Sciences. Department of Dermatology. Tokyo. JP
  • Nakagawa, Masahiro; Shizuoka Prefectural Cancer Center. Department of Plastic and Reconstructive Surgery. Nagaizumi. JP
  • Soejima, Toshinori; Kobe Proton Center. Department of Radiation Oncology. Kobe. JP
  • Koga, Hiroshi; Shinshu University. Department of Dermatology. Matsumoto. JP
  • Sugaya, Makoto; International University of Health and Welfare. Department of Dermatology. Narita. JP
J Dermatol ; 130(12): 288-311, 20210521.
Article em En | BIGG | ID: biblio-1292726
Biblioteca responsável: BR1.1
ABSTRACT
In consideration of the development of treatment options for squamous cell carcinoma (SCC), the Japanese Skin Cancer Society issued the first guidelines of SCC in 2007 and revised them in 2015. Here, we report the English version of the 2020 edition of the Japanese SCC guidelines. The first half of this article is an overview of SCC including actinic keratosis and Bowen's disease, and the second half discusses three clinical questions (i) treatment of actinic keratosis; (ii) determination of the resection margin of the primary lesion; and (iii) treatment of radically incurable cases, as contemporary problems encountered in treating SCC. In these evaluations, all processes were implemented according to the Grading of Recommendations, Assessment, Development, Evaluation system. Also, items of recommendation concerning each clinical question were determined by a multidisciplinary expert panel consisting of dermatologists, plastic/reconstructive surgeons, radiologists, and oncologists through a comprehensive literature search and systematic reviews.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 05-specialized Contexto em Saúde: 11_ODS3_cobertura_universal Base de dados: BIGG Assunto principal: Pele / Carcinoma de Células Escamosas Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Revista: J Dermatol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 05-specialized Contexto em Saúde: 11_ODS3_cobertura_universal Base de dados: BIGG Assunto principal: Pele / Carcinoma de Células Escamosas Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Revista: J Dermatol Ano de publicação: 2021 Tipo de documento: Article